1. Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma
   Hui Liu et al, 2015, Tumor Biology CrossRef
2. Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma
   Qian Zhu et al, 2022, Frontiers in Oncology CrossRef
3. Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine-induced killer cell therapy in hepatobiliary and pancreatic cancer
   LIHONG ZHANG et al, 2016, Molecular and Clinical Oncology CrossRef
4. Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors
   Clara E. Jäkel et al, 2014, Journal of Immunology Research CrossRef
5. Current Status of Immunotherapy Treatments for Pancreatic Cancer
   Cristina Jimenez-Luna et al, 2016, Journal of Clinical Gastroenterology CrossRef
6. Adoptive immunotherapy with autologous T-cell infusions reduces opioid requirements in advanced cancer patients
   Xinna Zhou et al, 2020, Pain CrossRef
7. Advances and Prospects in Cancer Immunotherapy
   Juhua Zhou, 2014, New Journal of Science CrossRef
8. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS)
   Y. Zhao et al, 2019, Clinical and Translational Oncology CrossRef
9. All-trans retinoic acid enhances cytotoxicity of CIK cells against human lung adenocarcinoma by upregulating MICA and IL-2 secretion
   Xiao-yan Fan et al, 2017, Scientific Reports CrossRef
10. Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study
    Ni Jiang et al, 2017, Clinical Cancer Research CrossRef
11. Development of Magnetic Nanoparticles for Cancer Gene Therapy: A Comprehensive Review
    Vladimir Mulens et al, 2013, ISRN Nanomaterials CrossRef
12. Cancer Immunotherapy: The Dawn of the Renaissance after the Medieval Dark Ages
    Dae Ho Lee, 2014, Korean Journal of Medicine CrossRef
13. Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review
    YONG ZHANG et al, 2015, Oncology Letters CrossRef
14. Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients
    Xiaoli Wang et al, 2019, Journal of Thrombosis and Thrombolysis CrossRef
15. Synthesis, characterization, and cytotoxicity evaluation of high-magnetization multifunctional nanoclusters
    Anca Petran et al, 2017, Journal of Nanoparticle Research CrossRef
16. Efficacy of RetroNectin-Activated Cytokine-Induced Killer Cell Therapy in Metastatic Brain Tumor Patients
    Wei Li et al, 2015, Oncology Research and Treatment CrossRef